Protagonist Therapeutics Return on Investment 2015-2019 | PTGX

Current and historical return on investment (ROI) values for Protagonist Therapeutics (PTGX) over the last 10 years.
Protagonist Therapeutics ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2019-12-31 $-0.08B $0.10B -80.60%
2019-09-30 $-0.08B $0.10B -103.65%
2019-06-30 $-0.07B $0.09B -140.70%
2019-03-31 $-0.05B $0.11B -177.78%
2018-12-31 $-0.04B inf%
2018-09-30 $-0.03B inf%
2018-06-30 $-0.03B inf%
2018-03-31 $-0.03B inf%
2017-12-31 $-0.04B inf%
2017-09-30 $-0.05B inf%
2017-06-30 $-0.05B inf%
2017-03-31 $-0.04B inf%
2016-12-31 $-0.03B inf%
2016-06-30 $-0.02B inf%
2016-03-31 $-0.01B inf%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.193B $0.000B
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The Company's initial lead product candidates consists of PTG-100 and PTG-200, which have the potential to transform the existing treatment paradigm for inflammatory bowel disease, a GI disease consisting primarily of ulcerative colitis and Crohn's disease; PTG-300, an injectable hepcidin mimetic. Protagonist Therapeutics, Inc. is based in Milpitas, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $119.572B 13.67
Gilead Sciences (GILD) United States $94.124B 12.18
CSL (CSLLY) Australia $83.000B 0.00
Vertex Pharmaceuticals (VRTX) United States $61.693B 55.99
Biogen (BIIB) United States $55.070B 9.40
Regeneron Pharmaceuticals (REGN) United States $53.721B 22.75
Illumina (ILMN) United States $40.149B 41.51
Alexion Pharmaceuticals (ALXN) United States $19.942B 9.25
Seattle Genetics (SGEN) United States $19.875B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.120B 0.00
Incyte (INCY) United States $15.874B 34.06
BioMarin Pharmaceutical (BMRN) United States $15.204B 650.00
Genmab (GMAB) Denmark $13.641B 10.70
BioNTech SE (BNTX) Germany $13.214B 0.00
Galapagos (GLPG) Belgium $12.670B 27.67
Alnylam Pharmaceuticals (ALNY) United States $12.308B 0.00
Genmab (GNMSF) Denmark $11.968B 38.49
Bio-Rad Laboratories (BIO.B) United States $10.513B 49.14
Moderna (MRNA) United States $9.854B 0.00
QIAGEN (QGEN) Netherlands $9.475B 28.89
Exact Sciences (EXAS) United States $8.582B 0.00
BeiGene (BGNE) Cayman Islands $8.019B 0.00
Sarepta Therapeutics (SRPT) United States $7.608B 0.00
Bio-Techne Corp (TECH) United States $7.272B 49.77
Guardant Health (GH) United States $6.569B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.563B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.632B 14.88
Ascendis Pharma (ASND) Denmark $5.376B 0.00
Exelixis (EXEL) United States $5.259B 16.88
Repligen (RGEN) United States $5.028B 91.94
ARGENX SE-ADR (ARGX) Netherlands $5.020B 0.00
Reata Pharmaceuticals (RETA) United States $4.796B 0.00
Acceleron Pharma (XLRN) United States $4.793B 0.00
China Biologic Products (CBPO) China $4.248B 25.22
Vir Biotechnology (VIR) United States $3.763B 0.00
Adaptive Biotechnologies (ADPT) United States $3.509B 0.00
Mirati Therapeutics (MRTX) United States $3.342B 0.00
MorphoSys AG (MOR) Germany $3.232B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.190B 0.00
Blueprint Medicines (BPMC) United States $3.160B 0.00
Global Blood Therapeutics (GBT) United States $3.108B 0.00
Emergent Biosolutions (EBS) United States $3.009B 20.89
Zai Lab (ZLAB) China $2.991B 0.00
NeoGenomics (NEO) United States $2.894B 125.50
Immunomedics (IMMU) United States $2.884B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.580B 43.72
Ultragenyx Pharmaceutical (RARE) United States $2.572B 0.00
Bluebird Bio (BLUE) United States $2.556B 0.00
Halozyme Therapeutics (HALO) United States $2.484B 0.00
Amicus Therapeutics (FOLD) United States $2.377B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.291B 0.00
Alkermes (ALKS) Ireland $2.275B 180.25
RA PHARMCTL INC (RARX) United States $2.272B 0.00
MyoKardia (MYOK) United States $2.183B 0.00
Arena Pharmaceuticals (ARNA) United States $2.110B 5.50
UniQure (QURE) Netherlands $2.100B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.068B 0.00
Principia Biopharma (PRNB) United States $1.960B 0.00
Viela Bio (VIE) United States $1.938B 0.00
Alector (ALEC) United States $1.895B 0.00
Eidos Therapeutics (EIDX) United States $1.887B 0.00
Denali Therapeutics (DNLI) United States $1.846B 0.00
Fate Therapeutics (FATE) United States $1.687B 0.00
Zymeworks (ZYME) Canada $1.615B 0.00
Arvinas (ARVN) United States $1.575B 0.00
Epizyme (EPZM) United States $1.563B 0.00
Akcea Therapeutics (AKCA) United States $1.445B 31.09
Insmed (INSM) United States $1.439B 0.00
Amarin (AMRN) Ireland $1.429B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.355B 0.00
Zealand Pharma (ZEAL) Denmark $1.244B 0.00
REGENXBIO (RGNX) United States $1.203B 0.00
Ligand Pharmaceuticals (LGND) United States $1.200B 37.29
Coherus BioSciences (CHRS) United States $1.146B 13.63
Editas Medicine (EDIT) United States $1.088B 0.00
Inovio Pharmaceuticals (INO) United States $1.085B 0.00
Twist Bioscience (TWST) United States $1.084B 0.00
Myriad Genetics (MYGN) United States $1.067B 18.83
NextCure (NXTC) United States $1.020B 0.00
PHARMA MAR SA (PHMMF) Spain $1.018B 0.00
Beam Therapeutics (BEAM) United States $0.894B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Intra-Cellular Therapies (ITCI) United States $0.852B 0.00
Revance Therapeutics (RVNC) United States $0.844B 0.00
NGM Biopharmaceuticals (NGM) United States $0.835B 0.00
Adverum Biotechnologies (ADVM) United States $0.778B 0.00
I-Mab (IMAB) China $0.742B 0.00
Sangamo Therapeutics (SGMO) United States $0.740B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.724B 0.00
Cytokineticsorporated (CYTK) United States $0.701B 0.00
Novavax (NVAX) United States $0.700B 0.00
Kadmon Holdings (KDMN) United States $0.669B 0.00
Codexis (CDXS) United States $0.657B 0.00
Arcus Biosciences (RCUS) United States $0.638B 0.00
Pharming Group (PHGUF) Netherlands $0.632B 0.00
Athenex (ATNX) United States $0.632B 0.00
Retrophin (RTRX) United States $0.629B 0.00
Cara Therapeutics (CARA) United States $0.617B 0.00
Bellus Health (BLU) Canada $0.600B 0.00
Intellia Therapeutics (NTLA) United States $0.598B 0.00
Intrexon (PGEN) United States $0.577B 0.00
GENFIT S.A (GNFT) France $0.560B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.556B 4.89
Frequency Therapeutics (FREQ) United States $0.551B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.544B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.543B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.522B 0.00
Castle Biosciences (CSTL) United States $0.513B 0.00
Compugen (CGEN) Israel $0.497B 0.00
MeiraGTx Holdings (MGTX) United States $0.495B 0.00
ANI Pharmaceuticals (ANIP) United States $0.493B 8.90
Athersys (ATHX) United States $0.492B 0.00
Mesoblast (MESO) Australia $0.471B 0.00
Clovis Oncology (CLVS) United States $0.467B 0.00
AC Immune SA (ACIU) Switzerland $0.467B 11.91
Sinovac Biotech (SVA) China $0.460B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.458B 0.00
Morphic Holding (MORF) United States $0.447B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.437B 0.00
Heska (HSKA) United States $0.433B 0.00
DBV Technologies S.A (DBVT) France $0.431B 0.00
Prothena (PRTA) Ireland $0.427B 0.00
Cel-Sci (CVM) United States $0.423B 0.00
Verastem (VSTM) United States $0.419B 0.00
Vericel (VCEL) United States $0.412B 61.13
Anika Therapeutics (ANIK) United States $0.410B 14.10
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.400B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.396B 0.00
Agenus (AGEN) United States $0.396B 0.00
Cellectis S.A (CLLS) France $0.391B 0.00
MiMedx (MDXG) United States $0.386B 0.00
AnaptysBio (ANAB) United States $0.385B 0.00
Cue Biopharma (CUE) United States $0.377B 0.00
UROGEN PHARMA (URGN) United States $0.373B 0.00
BioDelivery Sciences (BDSI) United States $0.365B 42.11
Scholar Rock Holding (SRRK) United States $0.361B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.354B 0.00
Merus (MRUS) Netherlands $0.351B 0.00
CytomX Therapeutics (CTMX) United States $0.349B 0.00
PDL BioPharma (PDLI) United States $0.349B 10.44
Kala Pharmaceuticals (KALA) United States $0.339B 0.00
Sorrento Therapeutics (SRNE) United States $0.334B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.332B 0.00
Puma Biotechnology (PBYI) United States $0.329B 0.00
WAVE Life Sciences (WVE) Singapore $0.324B 0.00
Precision BioSciences (DTIL) United States $0.310B 0.00
Cellular Biomedicine (CBMG) United States $0.306B 0.00
Dynavax Technologies (DVAX) United States $0.304B 0.00
Pfenex (PFNX) United States $0.302B 441.00
Avid Bioservices (CDMO) United States $0.289B 0.00
NantKwest (NK) United States $0.284B 0.00
Mersana Therapeutics (MRSN) United States $0.265B 0.00
Kamada (KMDA) Israel $0.260B 10.80
Syros Pharmaceuticals (SYRS) United States $0.257B 0.00
Seres Therapeutics (MCRB) United States $0.254B 0.00
ADMA Biologics Inc (ADMA) United States $0.249B 0.00
Albireo Pharma (ALBO) United States $0.245B 0.00
Stemline Therapeutics (STML) United States $0.244B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.242B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.240B 0.00
Geron (GERN) United States $0.238B 0.00
Sutro Biopharma (STRO) United States $0.236B 0.00
Aduro Biotech (ADRO) United States $0.221B 0.00
MannKind (MNKD) United States $0.219B 0.00
Gritstone Oncology (GRTS) United States $0.215B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.212B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.209B 1.88
Selecta Biosciences (SELB) United States $0.208B 0.00
Alcobra (ARCT) United States $0.206B 0.00
XOMA (XOMA) United States $0.199B 0.00
ChromaDex (CDXC) United States $0.195B 0.00
Starpharma Holdings (SPHRY) Australia $0.186B 0.00
HOOKIPA Pharma (HOOK) United States $0.180B 0.00
Abeona Therapeutics (ABEO) United States $0.176B 0.00
IVERIC Bio (ISEE) United States $0.171B 0.00
VBI Vaccines (VBIV) United States $0.169B 0.00
Spero Therapeutics (SPRO) United States $0.164B 0.00
OSMOTICA PHARM (OSMT) United States $0.164B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.164B 0.00
Biofrontera AG (BFRA) Germany $0.159B 0.00
Kindred Biosciences (KIN) United States $0.157B 0.00
Prometic Life Sciences (LMNL) Canada $0.157B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Fortress Biotech (FBIO) United States $0.148B 0.00
Cerecor (CERC) United States $0.143B 0.00
Dyadic (DYAI) United States $0.142B 0.00
Aytu Bioscience (AYTU) United States $0.136B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Liquidia Technologies (LQDA) United States $0.134B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.133B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Exicure (XCUR) United States $0.129B 0.00
VolitionRX (VNRX) United States $0.128B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.127B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.126B 0.00
VTv Therapeutics (VTVT) United States $0.125B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.124B 4.87
Theratechnologies (THTX) Canada $0.123B 0.00
Antibe Therapeutics (ATBPF) Canada $0.122B 0.00
Affimed (AFMD) Germany $0.120B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
AIT Therapeutics (XAIR) United States $0.117B 0.00
IBio (IBIO) United States $0.108B 0.00
Northwest Biotherapeutics (NWBO) United States $0.106B 0.00
Celyad SA (CYAD) Belgium $0.104B 0.00
Strongbridge Biopharma (SBBP) United States $0.103B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
Palatin Technologies (PTN) United States $0.097B 2.65
OvaScience (MLND) United States $0.096B 0.00
PHASEBIO PHARMA (PHAS) United States $0.095B 0.00
Aptinyx (APTX) United States $0.095B 0.00
CorMedix Inc (CRMD) United States $0.094B 0.00
TELA Bio (TELA) United States $0.089B 0.00
ARAVIVE, INC (ARAV) United States $0.084B 0.00
Checkpoint Therapeutics (CKPT) United States $0.083B 0.00
Five Prime Therapeutics (FPRX) United States $0.083B 0.00
Happiness Biotech Group (HAPP) China $0.079B 0.00
Clearside Biomedical (CLSD) United States $0.076B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.074B 0.00
Cyclerion Therapeutics (CYCN) United States $0.074B 0.00
Eton Pharmaceuticals (ETON) United States $0.073B 0.00
Orgenesis (ORGS) United States $0.070B 4.09
Arbutus Biopharma (ABUS) Canada $0.070B 0.00
Adocia (ADOCY) France $0.066B 0.00
Pluristem Therapeutics (PSTI) Israel $0.066B 0.00
Menlo Therapeutics (MNLO) United States $0.066B 0.00
Vaccinex (VCNX) United States $0.065B 0.00
SESEN BIO, INC (SESN) United States $0.062B 0.00
Applied Genetic Technologies (AGTC) United States $0.060B 0.00
Proteostasis Therapeutics (PTI) United States $0.059B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.058B 0.00
Emmaus Life Sciences (EMMA) United States $0.058B 0.00
Synlogic (SYBX) United States $0.055B 0.00
Trevena (TRVN) United States $0.055B 0.00
Organovo Holdings (ONVO) United States $0.054B 0.00
Catalyst Biosciences (CBIO) United States $0.053B 0.00
AquaBounty Technologies (AQB) United States $0.052B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.046B 0.00
Acorda Therapeutics (ACOR) United States $0.045B 0.00
Idera Pharmaceuticals (IDRA) United States $0.040B 0.00
Soligenix (SNGX) United States $0.040B 0.00
VIVUS (VVUS) United States $0.038B 0.00
Lumos Pharma (LUMO) United States $0.035B 0.00
CollPlant Holdings (CLGN) Israel $0.035B 0.00
Protalix BioTherapeutics (PLX) Israel $0.035B 0.00
AmpliPhi Biosciences (ARMP) United States $0.034B 0.00
DiaMedica Therapeutics (DMAC) United States $0.033B 0.00
Cocrystal Pharma (COCP) United States $0.033B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.033B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.033B 0.00
Advaxis (ADXS) United States $0.032B 0.00
Evogene (EVGN) Israel $0.030B 0.00
Celldex Therapeutics (CLDX) United States $0.029B 0.00
TOCAGEN INC (TOCA) United States $0.029B 0.00
Prima BioMed (IMMP) Australia $0.028B 0.00
Celsion (CLSN) United States $0.026B 0.00
Curis (CRIS) United States $0.026B 0.00
Signal Genetics (MGEN) United States $0.024B 0.00
Entera Bio (ENTX) Israel $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
BioCardia (BCDA) United States $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Pulmatrix (PULM) United States $0.021B 0.00
Alimera Sciences (ALIM) United States $0.020B 0.00
Stellar Biotechnologies (EDSA) Canada $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Oncobiologics (OTLK) United States $0.018B 0.00
Apricus Biosciences (SEEL) United States $0.018B 0.00
Bionano Genomics (BNGO) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
Unum Therapeutics (UMRX) United States $0.013B 0.00
AEterna Zentaris (AEZS) United States $0.012B 0.00
Aptevo Therapeutics (APVO) United States $0.012B 0.00
ATyr Pharma (LIFE) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Cesca Therapeutics (THMO) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
IMMURON (IMRN) Australia $0.006B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.006B 0.00
Spherix (AIKI) United States $0.002B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00